Filing Details
- Accession Number:
- 0000899243-15-008192
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-16 15:42:25
- Reporting Period:
- 2015-11-12
- Filing Date:
- 2015-11-16
- Accepted Time:
- 2015-11-16 15:42:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1512762 | Coherus Biosciences Inc. | CHRS | Biological Products, (No Disgnostic Substances) (2836) | 273615821 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1622055 | Christos Richards | C/O Coherus Biosciences, Inc. 201 Redwood Shores Parkway, Suite 200 Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Disposition | 2015-11-12 | 3,000 | $27.23 | 75,836 | No | 4 | S | Direct | |
| Common Stock, $0.0001 Par Value | Disposition | 2015-11-13 | 7,988 | $27.38 | 67,848 | No | 4 | S | Direct | |
| Common Stock, $0.0001 Par Value | Disposition | 2015-11-13 | 4,012 | $27.93 | 63,836 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $26.88 to $27.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $26.69 to $27.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $27.70 to $28.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
